» Articles » PMID: 24378425

Optical Coherence Tomography Predicts Visual Outcome in Acute Central Retinal Vein Occlusion

Overview
Journal Retina
Date 2014 Jan 1
PMID 24378425
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the clinical features of central retinal vein occlusion (CRVO) in relation to the presence of a prominent middle limiting membrane (p-MLM) sign on presenting optical coherence tomography, which may suggest macular ischemia and poor visual outcome.

Methods: Fifty consecutive eyes with acute CRVO of <1 month of symptom duration before presentation were retrospectively reviewed. A hyperreflective line located in the outer plexiform layer (p-MLM) in optical coherence tomography was used as a sign of acute ischemia. Cases with p-MLM were grouped and compared with the group of eyes with no p-MLM sign (non-MLM group) for clinical features including visual acuities, central fovea thickness, and CRVO types.

Results: Among the 50 eyes, 14 (28%) eyes showed a p-MLM sign, 21 (42%) eyes did not, and others had equivocal findings. Eyes with p-MLM sign presented worse initial and final best-corrected visual acuity compared with the non-MLM group (1.10 ± 0.72 vs. 0.47 ± 0.49 logMAR in the initial best-corrected visual acuity, P = 0.007; and 1.08 ± 0.86 vs. 0.32 ± 0.41 logMAR in the final best-corrected visual acuity, P = 0.044) in patients with a follow-up duration of 6 months or longer. The p-MLM group eyes showed a higher tendency toward being classified as ischemic type CRVO (57.1 vs. 4.8%, P = 0.001).

Conclusion: Central retinal vein occlusion showing p-MLM on optical coherence tomography had worse visual outcome with higher incidence of being classified into ischemic type CRVO.

Citing Articles

Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies.

Munk M, Ceklic L, Stillenmunkes R, Chaudhary V, Waheed N, Chhablani J Diagnostics (Basel). 2024; 14(17).

PMID: 39272767 PMC: 11394301. DOI: 10.3390/diagnostics14171983.


Evaluation of Anatomical and Tomographic Biomarkers as Predictive Visual Acuity Factors in Eyes with Retinal Vein Occlusion Treated with Dexamethasone Implant.

Covello G, Maglionico M, Figus M, Busoni C, Sartini M, Lupidi M J Clin Med. 2024; 13(15).

PMID: 39124798 PMC: 11313662. DOI: 10.3390/jcm13154533.


A Case Series of Retinal Artery Occlusion: When Time Is of the Essence.

Zokri M, Othman O Cureus. 2024; 16(5):e60520.

PMID: 38883137 PMC: 11180524. DOI: 10.7759/cureus.60520.


The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion.

Qu S, Zou Y, Yang L, Wu H Front Med (Lausanne). 2024; 10:1280776.

PMID: 38259837 PMC: 10800625. DOI: 10.3389/fmed.2023.1280776.


Severe Macular Ischemia Is Associated with a Poor Visual Prognosis and Serious Complications in Eyes with Central Retinal Vein Occlusion.

Kurobe R, Hirano Y, Yuguchi T, Suzuki N, Yasukawa T J Clin Med. 2023; 12(21).

PMID: 37959176 PMC: 10649895. DOI: 10.3390/jcm12216710.